Diseases of the esophagus : official journal of the International Society for Diseases of the EsophagusHumansEosinophilic EsophagitisAntibodiesMonoclonalHumanized
Lessons learned: real-world effectiveness of dupilumab in patients with eosinophilic esophagitis.
Carl Olson, Jameel Alp, Nicha Wongjarupong, Joshua A Sloan
Published: 202510.1093/dote/doaf123
Abstract
Eosinophilic esophagitis (EoE) is a chronic inflammatory disease of the esophagus. Dupilumab, an IL-4/IL-13 inhibitor, was approved for EoE in 2022, but real-world data remain limited. We evaluated its effectiveness in a single tertiary care center u…
Preview only. Read the full abstract at the source